BluGlass (BLG) H2 2024 earnings summary

Executive summary

• Achieved record annual revenue of A$10.1 million in FY24, up 6% year-over-year, with customer revenue up 307% to A$4.7 million, reflecting reduced reliance on R&D tax rebates.

• Secured major contracts, including a transformative A$2.6 million US Department of Defense CLAWS Hub contract and a one-off A$1.93 million IP payment from a European customer.

• Integrated GaNWorks Foundry into the Silicon Valley fab, enhancing manufacturing control and efficiency.

• Expanded partnerships with industry leaders, including Applied Energetics and UCSB, to drive innovation in GaN laser technology.

• Positioned for growth in the global visible GaN laser market, targeting quantum, defense, scientific, and biomedical sectors.

Financial highlights

• Consolidated loss for the year decreased by 14% to $10.14 million (2023: $11.75 million).

• Net assets increased by 7% to $14.89 million (2023: $13.89 million).

• Revenue from foundry services rose 128% to $2.5 million; laser diode project revenue was $2.05 million (2023: nil).

• R&D grant income declined 35% to $5.37 million.

• Gross expenditure decreased by 6% to $20.09 million.

• Cash and cash equivalents at year-end were $5.57 million, up from $4.26 million.

Outlook and guidance

• Focus remains on scaling laser diode market presence and validating RPCVD technology for industry acceptance.

• Ongoing strategy to win product development projects with add-on production potential and optimize manufacturing yields.

• Positioned to leverage high-value partnerships and collaborations for long-term growth and profitability.